Skip to main content
padlock icon - secure page this page is secure

Free Content Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa

Download Article:
 Download
(PDF)
 
The high cost of rifampicin‐resistant tuberculosis (RR‐TB) treatment hinders treatment access. South Africa has a high RR‐TB burden, and national policy outlines decentralisation to improve access and reduce costs. We analysed health system costs associated with RR‐TB treatment by drug resistance profile and treatment outcome in a decentralised programme.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Afrique du Sud; South Africa; Sudáfrica; TB ‐ MDR; TB‐MDR; TB‐RR; cost; costes; coût; decentralisation; descentralización; décentralisation; multidrug‐resistant tuberculosis; rifampicin‐resistant tuberculosis; traitement; tratamiento; treatment

Document Type: Research Article

Publication date: October 1, 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more